Are biochemical markers of neuroendocrine tumors coreleased with insulin following local calcium stimulation in patients with insulinomas?

Pancreas

Volumn 40, Issue 7, 2011, Pages 995-999

  Wiesli, Peter ^a   Uthoff, Heiko ^a   Perren, Aurel ^b   Pfammatter, Thomas ^c   Zwimpfer, Cornelia ^c   Seiler, Heidi ^c   Kindhauser, René ^a   Spinas, Giatgen A ^c   Schmid, Christoph ^c  

^a Kantonsspital Frauenfeld   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

arterial calcium stimulation and hepatic venous sampling test; chromogranin A; insulinoma; neuron specific enolase; pancreatic polypeptide

Indexed keywords

C PEPTIDE; CALCIUM; CHROMOGRANIN A; INSULIN; NEURON SPECIFIC ENOLASE; PANCREAS POLYPEPTIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INSULINOMA; MALE; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; TUMOR VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; C-PEPTIDE; CALCIUM GLUCONATE; CHROMOGRANIN A; FEMALE; HUMANS; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRA-ARTERIAL; INSULIN; INSULINOMA; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PANCREATIC POLYPEPTIDE; PHOSPHOPYRUVATE HYDRATASE; PREDICTIVE VALUE OF TESTS; PROTEIN PRECURSORS; SWITZERLAND; TUMOR MARKERS, BIOLOGICAL;

EID: 80052967561     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0b013e31821ffce1     Document Type: Article

References (25)

1. Portela-Gomes G, Grimelius L, Wilander E, et al. Granins and granin-related peptides in neuroendocrine tumours. Regul Pept. 2010;165(1):12-20. Epub 2010 Mar 6.
2. Taupenot L, Harper K, O'Connor D. The chromogranin-secretogranin family. N Engl J Med. 2003;348:1134-1149. (Pubitemid 36337325)
3. O'Connor D, Frigon R. Chromogranin A, the major catecholamine storage vesicle soluble protein. Multiple size forms, subcellular storage, and regional distribution in chromaffin and nervous tissue elucidated by radioimmunoassay. J Biol Chem. 1984;259:3237-3247. (Pubitemid 14159450)
4. O'Connor D, Deftos L. Secretion of chromogranin A by peptide-producing endocrine neoplasms. N Engl J Med. 1986;314:1145-1151. (Pubitemid 16138661)
5. Doppman J, Miller D, Chang R, et al. Insulinomas: Localization with selective intraarterial injection of calcium. Radiology. 1991;178:237-241.
6. Doppman J, Chang R, Fraker D, et al. Localization of insulinomas to regions of the pancreas by intra-arterial stimulation with calcium. Ann Intern Med. 1995;123:269-273.
7. Tseng L, Chen J, Won J, et al. The role of intra-arterial calcium stimulation test with hepatic venous sampling (IACS) in the management of occult insulinomas. Ann Surg Oncol. 2007;14:2121-2127. (Pubitemid 46988266)
8. Guettier J, Kam A, Chang R, et al. Localization of insulinomas to regions of the pancreas by intraarterial calcium stimulation: The NIH experience. J Clin Endocrinol Metab. 2009;94:1074-1080.
9. Wiesli P, Brändle M, Pfammatter T, et al. Insulin determination by specific and unspecific immunoassays in patients with insulinoma evaluated by the arterial stimulation and venous sampling test. Eur J Endocrinol. 2004;151:123-126. (Pubitemid 39117374)
10. Wiesli P, Spinas G, Pfammatter T, et al. Glucose-induced hypoglycaemia. Lancet. 2002;360:1476. (Pubitemid 35356326)
11. Perren A, Wiesli P, Schmid S, et al. Pancreatic endocrine tumors are a rare manifestation of the neurofibromatosis type 1 phenotype: Molecular analysis of a malignant insulinoma in a NF-1 patient. Am J Surg Pathol. 2006;30:1047-1051. (Pubitemid 44264957)
12. Brändle M, Pfammatter T, Spinas G, et al. Assessment of selective arterial calcium stimulation and hepatic venous sampling to localize insulin-secreting tumours. Clin Endocrinol (Oxf). 2001;55:357-362. (Pubitemid 32823046)
13. Perren A, Weng L, Boag A, et al. Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast. Am J Pathol. 1999;155:1253-1260. (Pubitemid 29488932)
14. O'Toole D, Grossman A, Gross D, et al. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Biochemical markers. Neuroendocrinology. 2009;90:194-202.
15. Reiffen F, Gratzl M. Chromogranins, widespread in endocrine and nervous tissue, bind Ca2+. FEBS Lett. 1986;195:327-330. (Pubitemid 16049011)
16. Gorr S, Shioi J, Cohn D. Interaction of calcium with porcine adrenal chromogranin A (secretory protein-I) and chromogranin B (secretogranin I). Am J Physiol. 1989;257:E247-E254.
17. Gerdes H, Rosa P, Phillips E, et al. The primary structure of human secretogranin II, a widespread tyrosine-sulfated secretory granule protein that exhibits low pH- and calcium-induced aggregation. J Biol Chem. 1989;264:12009-12015. (Pubitemid 19185376)
18. Yoo S, Albanesi J. High capacity, low affinity Ca2+ binding of chromogranin A. Relationship between the pH-induced conformational change and Ca2+ binding property. J Biol Chem. 1991;266:7740-7745. (Pubitemid 21906427)
19. Schmechel D, Marangos P, Brightman M. Neurone-specific enolase is a molecular marker for peripheral and central neuroendocrine cells. Nature. 1978;276:834-836. (Pubitemid 9061995)
20. Lloyd R, Mervak T, Schmidt K, et al. Immunohistochemical detection of chromogranin and neuron-specific enolase in pancreatic endocrine neoplasms. Am J Surg Pathol. 1984;8:607-614. (Pubitemid 14055019)
21. Cunningham R, Johnston C, Irvine G, et al. Serum neurone-specific enolase levels in patients with neuroendocrine and carcinoid tumours. Clin Chim Acta. 1992;212:123-131.
22. Nobels F, Kwekkeboom D, Coopmans W, et al. Chromogranin A as serum marker for neuroendocrine neoplasia: Comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones. J Clin Endocrinol Metab. 1997;82:2622-2628. (Pubitemid 27337883)
23. Panzuto F, Severi C, Cannizzaro R, et al. Utility of combined use of plasma levels of chromogranin A and pancreatic polypeptide in the diagnosis of gastrointestinal and pancreatic endocrine tumors. J Endocrinol Invest. 2004;27:6-11. (Pubitemid 38324712)
24. Liu Y, Hellman B, Gylfe E. Ca2+ signaling in mouse pancreatic polypeptide cells. Endocrinology. 1999;140:5524-5529. (Pubitemid 30645339)
25. Turner J, Wren A, Jackson J, et al. Localization of gastrinomas by selective intra-arterial calcium injection. Clin Endocrinol (Oxf). 2002;57:821-825. (Pubitemid 36963010)